Alan J. Gelenberg joined Healthcare Technology Systems as President and CEO

Alan J. Gelenberg, M.D., has joined Healthcare Technology Systems, Inc. (HTS) as President and CEO, bringing his decades of academic, clinical and executive medical experience.

Healthcare Technology Systems (www.healthtechsys.com), headquartered in Madison, Wisconsin, pioneered the development of clinical interactive voice response (IVR) systems to collect data directly from patients for pharmaceutical companies, healthcare organizations, and researchers. HTS also creates software to enhance patient care and clinical research in psychiatry and other specialties.

Dr. Gelenberg joins founding directors John H. Greist, M.D., James W. Jefferson, M.D., and David J. Katzelnick, M.D.

Since 1987 Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, the world’s most widely read peer-reviewed psychiatry journal. He is also founding author of Biological Therapies in Psychiatry Newsletter, in its 31st year. He will continue both endeavors through his involvement with HTS.

Dr. Gelenberg Background
For 18 years, Gelenberg was Professor and Head of the University of Arizona’s Department of Psychiatry, where he is now Professor Emeritus. Previously, Dr. Gelenberg was on the faculty of Harvard University and Massachusetts General Hospital for 19 years and also on the faculty of the Massachusetts Institute of Technology. He received an A.B. from Columbia University and an M.D. from the University of Pennsylvania.

Dr. Gelenberg was lead author of manuscripts in the Lancet, New England Journal of Medicine, and Journal of the AMA and authored over 200 scientific articles, editorials, and book chapters. He chairs the American Psychiatric Association’s (APA) workgroup on Treatment Guidelines for Major Depressive Disorder, worked with a joint APA/AMA taskforce on similar guidelines for primary care, and currently advises the U.S. Centers for Disease Control on depression. He helped develop the ASEX scale to track sexual side effects of antidepressants and continues working on means to improve clinical trial methods.

Dr. Gelenberg has served on several committees for the National Institute of Mental Health, is a Distinguished Life Fellow of the APA, former chair of its Committee on Research on Psychiatric Treatments, past President of the West Coast College of Biological Psychiatry, and a fellow of the American College of Neuropsychopharmacology. He is on the Scientific Advisory Board of the Depression and Bipolar Support Alliance.

Healthcare Technology Systems
With academic origins at the University of Wisconsin and more than three decades of published research, HTS and its principals are world renowned for their research expertise, educational accomplishments, and innovative computer-administered rating scales. The U. S. Food and Drug Administration in 2004 issued a statement regarding the acceptability of Interactive Voice Response (IVR) self-report instruments that assess severity of illness in Major Depressive Disorder with special attention to the Hamilton Depression Rating Scale (HAMD), the Inventory of Depressive Symptomatology (IDS), and the Quick Inventory of Depressive Symptomatology (QIDS). Twenty major pharmaceutical companies have used its clinical IVR assessments to qualify study subjects for trial entry and collect efficacy, quality of life, pharmacoeconomic and patient diary information. HTS also offers validated personalized IVR self-help programs for patients.

For further information, contact Sandy Steinhauer

Healthcare Technology Systems, Inc.

7617 Mineral Point Road, Suite 300

Madison, WI 53717

(608) 827-2440 - Phone

(608) 827-2444 - Fax